Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients.

Grifols is gearing up to file for approval of a drug for rare bleeding disorder acquired fibrinogen deficiency (AFD) that could provide a more reliable and easier treatment for patients.

The new application covers both supplementation in patients with acquired fibrinogen deficiency and treatment and prophylaxis of acute bleeding episodes in all patients with congenital fibrinogen ...

Another important aspect of recent studies is the investigation of genetic mutations affecting fibrinogen ... the mechanisms of autoimmune-acquired Factor XIII deficiency (AiF13D).

Grifols claims that its fibrinogen, which treats fibrinogen deficiency associated with severe blood loss, is designed to be more convenient and faster to prepare than alternatives. The European ...

Floyd, the Detroit-based direct-to-consumer furniture brand, has been acquired. The buyer is Rize Home, a Cleveland-based company that manufactures and imports beds and bedding. Financial terms of the ...

Belgian distributor Piece of Magic has acquired distribution rights for France and Benelux for Luna Carmoon’s “Hoard,” which is BAFTA nominated in the outstanding debut by a British ...

Coagulation factor deficiency or dysfunction due to inherited or acquired coagulation disorders impair hemostasis ... there are also other rare bleeding disorders due to deficiencies in Factor I ...